Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
256 Cards in this Set
- Front
- Back
extracellular bacterial infections: most important factor =
|
adhesion
|
|
if bacteria don't adhere to epithelium, they don't:
|
infect
|
|
"epithelial surface" =
|
skin or lining of gut
|
|
first solutionto adhering bacteria:
|
slough off the epithelial cells
|
|
if unable to slough, solution to adhering bacteria =
|
Innate Immunity
- macrophages and neutrophils phagocytose the bact. |
|
**neutorphils are WAY better at ________________ than macrophages**
|
phagocytosis
|
|
if the innate immunity response is efficient, AI is not
|
necessary
|
|
if InnImm is not effective at killing bacteria, the bacteria will continue to proliferate, =>
|
more bacterial load, for longer
= AI is necessary |
|
(normal infection => inflammatory signals =>
|
WBC's called in)
**inflammatory signals are critical for survival** |
|
**what do extracellular toxigenic bacteria do?**
|
**actually kill neutrophils**
|
|
example of extracellular toxigenic bacterium =
|
B. pertussis
|
|
solution to extracell. toxigenic bact = AI, via:
(2) |
1. B cells + T helper cells become plasma cells and release AB's
2. memory cells combat reinfection |
|
**how do AB's combat bacterial toxin?**
|
they **neutralize** the toxin, allowing macrophages and neutrophils to phag. the bact. wherever they've spread (over epithelium or within the cells at that point)
|
|
Paradigm 1 of immunity: the AI __________ the InnImm
|
*recruits*
|
|
**vaccine =
|
inactivated bact/viral toxing, antigen, etc
- used to create memory cells that then combat reinfection |
|
3 kinds of bact. that grow in the interstitium (between cells):
|
1. capsular bact.
2. invasive bact. 3. bact. that prevent inflammation |
|
capsular bacteria:
(2) |
1. grow in interstitium
2. capsule makes them resistant to pahgocytosis |
|
response to capsule of capsular bacteria =
|
Complement opsonizing
|
|
what does opsonosis do to capsular bacteria?
|
makes it easier for neutrophils to phag.
|
|
why is Complement not an ideal response?
|
b/c Complement is part of the II and therefore general
|
|
AI opsonization is better b/c:
|
it's specific to that antigen
|
|
Paradigm 2 of immunity: the AI =
|
the InnImm x 10
|
|
3 examples where AI is 10 times more powerful than II:
|
1. opsonization
2. neutrophil influx (for invasive bact.) 3. macrophage priming/optimization |
|
deficiency in opsonization =>
|
susceptibility to *encapsulated* bact.
|
|
example of invasive toxigenic bact:
|
Staph aureus
|
|
what does an invasive bacterium's toxin do?
|
**takes out neutrophils in the surrounding area (in the interstitium)
|
|
despite losing lots of neutrophils to the invasive toxin, the InnImm still:
|
*prevents the spread* of infection
- allows AI to kick in |
|
it normally takes the AI _________ to kick in
|
7 days
|
|
**what's the AI response to invasive toxigenic bact?**
(2) |
1. AB's (which neutralize the toxin)
2. Th17 |
|
what does Th17 do for invasive toxigenic bact. infections?
|
**sustains/boosts neutrophil influx**
- brings in WAY more neutrophils than the II can |
|
what's the worst kind of bacterial infection?
|
on in which the bacteria **prevent** the inflammatory signal from being released by infected cells
- tells neutrophils, "go away, we're good here" |
|
**what does no inflammation signal mean?**
|
**bact. replicate unchecked
=> 50% mortality rate |
|
best example of bact. that prevent the inflammation signal =
|
Yersinia pestis
(aka the plague) |
|
the plague ~
|
a complete lack of II response
|
|
with a normal inflammation signal, the II would still be able to:
|
keep the bacteria in check as AI booted up, even if the II wasn't strong enough to overcome the bact.
|
|
***early inflammation, particularly via neutrophils, is critical to:***
|
hold the line until the AI comes in
|
|
chronic granulomatous disease =
|
NO ROS from neutrophls/macrophages => cannot kill bacteria
=> EVERY bacterium becomes a plague |
|
2 kinds of intracellular bacterial infections:
|
1. cytosolic
2. vasicular |
|
best example of cytosolic bact. infection =
|
Listeria mono
|
|
cystolic bact. infection:
(4) |
1. bact. replicate *within* epithelial cells, to avoid detection
2. spread to the next one over, instead of releasing itself to the outside 3. not common 4. eventually replicate too much => can't avoid detection any longer => II discovers infected cell, phag's it |
|
defenses against cytosolic bacterial infections:
(4) |
1. autophagy (just swallow it, within the cell)
2. infected cells release cytokines that call up the II (=> macrophages/neutrophils are there when infected cells blows up) 3. CTL's 4. Th1's (to upgrade/prime macrophages) |
|
the cytosol is actually _________________ to bacteria
|
inhospitable
|
|
vesicular intracellular bact. infections, like cytosolic, also:
|
replicate within/spread from cell to cell
|
|
***some intracellular bact. infections have macrophage subversion, which means:***
|
the ability to infect a macrophage and use it to grow, instead of being phag'd by it
=> MORE bact. released |
|
soln to intracellular bact. infections = the AI, via:
(2) |
1. Th1 cells
2. AB targeting to neutralize and hold the bact. |
|
what do Th1 cells do for intracellular bact. infections?
|
they release IFN-y
=> primes macrophages to combat subversion, by becoming **as good** at phagocytosing as neutrophils |
|
why aren't macrophages normally as good at phagocytosing as neutrophils?
|
they would harm tissue via ROS
|
|
upgraded macrophages are less likely to get taken over because:
|
they are better at killing bact now
|
|
tuberculoid leprosy ~
|
too strong Th1
|
|
fungal infections:
(2) |
1. fungi like cooler environments
2. hard to clear |
|
if extracellular, fungal infections are killed by:
|
neutrophils
- a neutrophil influx is caused by Th17 |
|
intracellular vacuolar fungi can ALSO take over:
|
macrophages
- also combated by Th1 priming via IFN-y |
|
with parasites, chronic infection is very:
|
common
|
|
worms trigger:
|
Th2 cells => B cells make IgE => IgE calls up mast cells, which call up eosinophils
=> eosinophils dog-pile the worm and release their toxic granules |
|
aberrant Th2 response ~
(2) |
allergy and asthma
|
|
viral infections are, by definition:
|
intracellular, and cytosolic
|
|
viruses have STRONG anti-__________ abilities
|
InnImm
|
|
4 defenses against viruses:
|
1. anti-viral proteins
2. NK's 3. CTL's 4. AB's (to mop up and bind viruses after CTL's are done, preventing them from entering cells) |
|
anti-viral proteins are made by:
|
the infected cell,
following type 1 IFN signalling |
|
NK's are general, and so are not:
|
as effective as CTL's
|
|
viruses attempt to antagonize:
|
EVERY step of the immune response, including MHC at every point
|
|
viruses, bacteria, and parasites use a trick called:
|
AB escape
|
|
AB escape ~~
|
creating new surface epitopes
|
|
HIV makes new epitopes ___________
|
weekly
=> continual evasion of AB's |
|
HIV also takes out ALL types of:
|
CD4+ cells
|
|
danger level 1 infection:
|
toxigenic bacteria on epithelial surfaces
|
|
danger level 2 infection:
|
toxigenic *invasive* bact., within the interstitium
|
|
danger level 3 infection:
|
bact. that *prevent inflammatory signal*, also in the interstitium
|
|
goal of vaccines is to prevent:
|
*disease,*
not prevent infection |
|
most vaccines produce:
|
AB's
|
|
3 factors triggered by vaccines:
|
1. AB's
2. CD8+ cells 3. CD4+ cells |
|
***what do Ab's do?***
(4) |
1. opsonize
2. neutralize 3. enhance phag. by macrophages/meutrophils 4. activate Complement cascade |
|
vaccines are presented by:
|
MHC,
just like they do antigens |
|
why are germinal center B cells critical for effective AB response?
|
B cells activated by antigen outside the germinal centers are **short-lived** and **cannot make memory cells**
|
|
light zone =
|
follicular dc's presenting antigen to B cells, which are then activated by nearby T cell helpers
|
|
dark zone =
|
rapidly-dividing, *activated* B cells
|
|
somatic hypermutation occurs:
|
when the B cells are prolif/diff. in the dark zone
|
|
**long-living plasma cells colonize the:
|
bone marrow, releasing their AB's to blood over years
|
|
***long-living memory cells from germinal centers DON'T NEED:***
|
T cell help to be activated
|
|
adjuvants =
|
mlcls added to vaccines in order to trick the immune system into seeing an infection and **activating the II**
which activates the AI |
|
the InnImm system is critical for:
|
activating the AI
|
|
**protein** antigens by themselves are poor:**
|
vaccines, b/c they don't activate the InnImm very well
=> **need adjuvants** |
|
polysaccharide antigens stimulate:
|
**T-independent** AB response
|
|
why do polysaccharide antigens only stimulate T-INDependent AB responses?
|
**b/c T cells can only recognize **peptides**
|
|
polysaccharide antigens are poor vaccines b/c:
(3) |
1. don't cause germ. center rxn
2. innefficient class switching 3. NO B memory cells produced |
|
why are polysaccharide vaccines necessary?
|
many pathogens have a **polysaccharide capsule**
|
|
solution to poor immune response to polysaccharides =
|
add protein adjuvant that links to polysaccharide vaccine
=> T-dependent response => **called a conjugate vaccine** |
|
conjugate vaccine =
|
polysaccharide vaccine with protein adjuvant
(T-dependent response) |
|
the very young and the very old have limited:
|
AB responses to polysaccharides and proteins
|
|
primary immunodeficiency =
|
**genetic** mutation
that messes up any step of the immune response |
|
primary immunodeficiency =>
|
great susceptibility to infections, autoimmunity, and sometimes malignancy
|
|
inheritance of primary immdef's is:
|
AD, AR or X-linked
|
|
primary immdef's are most readily spotted in:
|
childhood
|
|
most PID's are:
|
**AB deficiencies**
|
|
4 kinds of secondary immdef's:
|
1. HIV
2. Trauma 3. nephrotic syndromes 4. intestinal lymphangiectasia |
|
nephrotic syndromes ~
|
loss of factors like Ig and Complement
|
|
intestinal lymphangiectasia =
|
loss of lymph, with its Ig's and lymphocytes, into the gut
|
|
***3 categories of immunodeficiency:***
|
1. Humoral
2. Cellular/Combined 3. Innate Immune def's |
|
humoral immunity ~
(2) |
AB's and Complement
|
|
humoral immunity:
(3) |
1. most common kind
2. ~frequent pyogenic infections 3. ~ chronic diarrhea |
|
diagnosing immdef's: think:
(2) |
quantity and quality
(what are they doing, or not doing) |
|
"pyogenic" ~
|
inflammation and pus, usually due to bacteria
|
|
AB's and Complement work in:
|
concert
|
|
hereditary angioedema is the result of a deficiency in:
|
**Complement** C1 esterase inhibitor
|
|
hereditary angioedema =
|
massive swelling of face *wihtout* itching or hives
(NOT an allergy - no itching) |
|
6 specific AB (and thus humoral) deficiencies:
|
1. XLA
2. Hyper IgM Syndrome 3. IgA deficiency 4. CVID 5. Specific AB deficiency 6. Transient Hypogammaglobulinemia of infancy |
|
XLA stands for:
|
X-linked Agammaglobulinemia
|
|
in XLA, the germinal centers are:
|
**defective**
|
|
result of defective germinal centers =
|
defects in B cell maturation
- specifically, BTK of pre-B cell doesn't work => no maturation |
|
no maturation of B cells =>
(2) |
1. lack of AB's and B memory cells
2. underdveloped tonsils, Peyer's patches, spleen, and lymph nodes |
|
XLA:
(3) |
1. common in boys (duh)
2. B cells < 2% of lymphocytes 3. *normal* T cell # and func |
|
Hyper IgM Syndrome =
|
normal number of B cells, but disproportionate expression of IgM vs. the other classes
|
|
Hyper IgM is the result of:
|
impaired class switching, via 2 mechanisms
|
|
2 mechanisms of impaired class switching in Hyper IgM:
|
1. defective signal to induce class switching
2. defective machinery to make the class switching happen |
|
what's the most common form of defective signaling in impaired class switching?
|
bad CD40L
- it's X-linked (bad CD40 ~ AR) |
|
IgA deficiency:
(3) |
1. most common immdef
2. usually asymptomatic 3. undetectable amounts of IgA |
|
CVID stands for:
|
Common Variable Immuno Deficiency
|
|
CVID:
(4) |
1. most common PID in adults
2. ~ reduced IgG, IgA, and/or IgM in serum 3. => absent or impaired specific AB response to previous infections/vaccines 4. => recurrent infections (so life-threatening) |
|
CVID results in an increased risk of:
(4) |
1. granulomatous diseases,
2. autoimmune disorders 3. splenomegaly 4. certain malignancies |
|
Specific AB deficiency =
|
impaired AB response to **encapsulated* bact.
(and thus to polysaccharide vaccines) |
|
Spcific AB deficiency:
(3) |
1. recurrent sinopulmonary infections
2. normal B cell number 3. normal T cell number and function |
|
one NEEDS ________ AND __________ to take down encapsulated bacteria
|
AB's
and Complement |
|
transient hypogammaglobulinemia of infancy =
|
delay in maturation of T helper cells for AB production
=> recurrent sinopulmonary infections |
|
onset of transient hypogammaglob. =
|
6 months
- resolved by age 4 |
|
IgG does a lot of:
|
things
|
|
lack of NK's =>
|
increased susceptibility to Herpes virus family
|
|
cellular immdef's ~
|
**lack of T cells**
|
|
Cellular ImmDef's are often called "Combined ImmDef's" because:
|
a lack of T cells means a lack of T helpers which means a lack of B cell activation
|
|
(CD4+ cells enhance:
|
CD8+'s, NK's, and macrophages)
- and of course activate B cells |
|
clinical characteristics of T cell dysfunction:
(5) |
1. recurrent **intracellular** infections
2 **thrush** (classic) 3. failure to thrive (esp. due to diarrhea) 4. eczemous rash 5. anergy to antigens |
|
which pathogens grow intracellularly?
(4) |
viruses, some bact, fungi, and protozoa
|
|
5 different Combined immdef's:
|
1. SCID
2. DiGeorge Syndrome 3. Bare Lymphocyte Syndrome type II 4. Wiskott Aldrich Syndrome 5. Hyper IgE (Job's Syndrome) |
|
SCID =
|
profound deficiency of T cells
=> NO AI |
|
why does SCID occur?
|
B and T cells need some of the same proteins to mature
(e.g. ADA or RAG) - lack of one of these prot's messes with both lines |
|
DiGeorge Syndrome =
|
smaller or absent thymus
|
|
DiGeorge Syndrome is the result of:
|
defective development of 3rd and 4th pharyngeal pouch
|
|
DiGeorge Syndrome is diagnosed immediately by:
|
the absence of a thymic shadow on X-ray
|
|
clinical features of DiGeorge Syndrome:
(4) |
1. depressed T cell immunity
2. dysmorphic face 3. hypocalcemia (due to lack of PTH) 4. congenital heart disease |
|
***DiGeorge is either:
|
hypoplastic (partial)
or aplastic (complete DiGeorge) |
|
***features of partial DiGeroge:***
(6) |
1. more common
2. +Hassell's corpuscles 3. **normal thymic function** 4. T cell function is adequate 5. B cells normal 6. usually free of infections |
|
***features of complete DiGeorge:***
(3) |
1. NO thymus
2. very few CD4+ cells 3. AB response is decreased |
|
Bare Lymphocyte Syndrome, type II =
|
defective expression of class II MHC
= AR disease that looks like SCID |
|
BLS type II:
(3) |
1. impaired T cell activation
2. impaired maturation of CD4+ cells 3. normal/elevated CD8+ |
|
Wiskott Aldrich Syndrome has 3 symptoms:
|
1. eczema
2. thrombocytopenia 3. immunodeficiency |
|
thrombocytopenia =
|
deficiency of platelets in the blood
|
|
what causes Wiskott Aldrich Syndrome?
|
defective WASProtein
|
|
WASp ~
|
actin polymerization
|
|
Hyper IgE:
(4) |
1. severe eczema
2. cold abscesses 3. patients have retained primary teeth 4. high IgE |
|
Job's Syndrome is due to impaired function of:
|
Th17 cells
|
|
3 types of Innate Immdef's:
|
1. chronic granulomatous disease
2. leukocyte adhesion deficiency 3. TLR deficiencies |
|
Chronic Granulomatous Disease =
|
recurrent bacterial infections due to impaired ability of macrophages and neutrophils
|
|
CGD:
(3) |
1. granulomas of skin, liver, lungs, lymph nodes
2. problems with wound healing 3. diagnosed with flow cytometry |
|
which immune cells specialize in wound healing?
|
neutrophils
|
|
in CGD, phagocytotic cells are able to ingest the bact. but not:
|
kill it
- can't produce the necessary ROS burst |
|
leaukocyte adhesion deficiency =
|
neutropils can't migrate or adhere
=> can't get to infected tissue |
|
LAD is diagnosed by:
(2) |
1. delayed umbilical cord separation
2. crazy-high WBC count but NO PUS |
|
diagnosing immdef's:
(3) |
1. growth chart
2. onset of symptoms 3. palpate lymph nodes |
|
as a result of no T cells to activate B cells, humoral immunity is impaired in:
|
combined immdef's
|
|
tolerance =
|
not responding to self-antigens
|
|
central tolerance ~
(2) |
bone marrow and thymus
|
|
***what is responsible for addressing autoreactive cells that don't apoptose or anergize?***
|
**regulatory T cells**
|
|
what's one condition that results from a failure of central tolerance?
|
Autoimmune Polyglandular Syndrome (APS1)
|
|
APS1 is the result of a defect in:
|
AIRE, which normally drives elimination of autoreactive cells
(automimmune regulator mlcl) |
|
3 mechanisms of peripheral tolerance:
|
1. anergy
2. suppression by regulatory T cells 3. apoptosis |
|
anergy of autoreactive cells is achieved by:
|
**blocking signal 2**
|
|
apoptosis of autoreactive cells is achieved by:
(2) |
1. expression of pro-apoptotic prot's
2. death receptors (both of them => caspases => apoptosis |
|
IPEX is an autoimmune disease that results from a failure to:
|
suppress autoreactive cells via regulatory T cells
|
|
ALPS stands for:
|
Autoimmune Lymphproliferative Syndrome
|
|
ALPS =
|
uncontrolled expansion of potentially harmful autoreactive lymphocytes
|
|
both B and T cells can be:
|
autoreactive
|
|
central B cell tolerance takes 2 forms:
|
central deletion;
receptor editing |
|
breakdowns in tolerance =>
(2) |
autoimmunity or hypersensitivity
|
|
breakdowns in tolerance occur due to:
|
nature and nurture
|
|
hypersensitivity =
|
immune rxns that cause damage to the *body*
(rather than a pathogen) |
|
Type I hypersensitivity is actually:
|
allergy
- IgE-mediated |
|
"allergy" = B cells make IgE =>
|
IgE attaches to IgE r's on mast cells => r's form crosslink and bind antigen => mast cell is activated => release of histamine and recruitment of other WBC's to site (i.e. inflammation)
|
|
allergic rxns generally happen within:
|
5 to 10 minutes of exposure
|
|
***allergies always cause:***
|
itching
(due to histamine) |
|
3 forms of allergic rxn:
|
1. atopic (quick) dermatitis
2. rhinitis 3. asthma |
|
atopic drmatitis usually occurs within:
|
the first year of life
|
|
rhinitis =
|
inflammation of mucous membrane of nose
|
|
anaphylaxis =
|
sever allergic rxn
|
|
anaphylaxis is the result of:
|
massive amount of mast cells and basophils
=> massive amount of histamine |
|
anaphylaxis =>
(5) |
1. hives
2. flushing 3. airway constriction 4. drop in BP 5. vomiting |
|
50% of cases of anaphylaxis are caused by:
|
food
|
|
peanuts are dangerous b/c they're:
|
heat resistant
|
|
treatment of asthma comes in 2 forms:
|
1. rescue via albuterol or xopenex (B-agonists)
2. control inflammaiton via steroids |
|
IgM ~
|
first response
|
|
IgD ~
|
mature B cells
|
|
IgG ~
|
secondary response
|
|
IgA ~
|
protecting mucosa by preventing bacterial adherence
|
|
IgE ~
|
mast cells/basophils/inflammation
|
|
Type II, III, and IV Hypersensitivity are all:
|
**autoimmunity**
|
|
Type II hypersensitivity =
|
IgM or IgG **AB's act directly against tissue**
(via tissue self-antigens) => tissue damage |
|
3 types of Type II HS:
|
1. Complement and Fcr' - mediated inflammation
2. opsonization and phag. 3. anti-tissue AB's |
|
anti-tissue AB's can damage tissue by either:
|
activating r's OR inhibiting them
|
|
Type III HS:
(2) |
1. AB-mediated
2. antigens can be either foreign OR self-antigens (tissue damage occurs either way) |
|
***difference between Type II and Type III HS =
|
Type III makes deposits of **immune complexes** in tissues, esp. vessel walls
- the complex is the pathology |
|
**immune complex** =
|
large, insoluble antigen-AB complex
|
|
if an immune complex is deposited in vessels of the skin, it's called:
|
vasculitis
|
|
vasculitis:
(3) |
1. usually in small vessels
2. immune complex absorbs Complement => **low blood Complement levels** 3. ~ rashes |
|
classic example of Type III HS =
|
Lupus
|
|
**type III HS rxn to a FOREIGN antigen is called:**
|
serum sickness
|
|
symptoms of serum sickness =
(3) |
1. hives
2. fever 3. joint pain/stiffness |
|
serum sickness is the result of:
|
medications, particularly high does of IV AB's
occurs couple weeks after administration, ends a couple of weeks after end of discontinuation |
|
one treatment of Type III HS is to decrease the immune response with:
|
cytotoxic agents
|
|
best drug to decrease immune response =
|
Rituximab
|
|
Rituximab:
(2) |
1. anti-CD20 agent
2. depletes autoreactive B cells |
|
(CD20 =
|
r' on B cells)
|
|
caveat with using Rituximab:
|
it can give you secondary immdef due to depleting B cells
|
|
Type IV HS has NOTHING to do with:
|
**AB's**
|
|
Type IV HS causes tissue injury via:
(2) |
1. CD4+ cells secreting cytokines => inflammation, activated macrophages
2. CD8+ cells directly injuring your cells can be one or both of these at the same time |
|
in either case of Type IV mechanism, the damage is directed at:
|
YOU,
not a pathogen |
|
common examples of Type IV HS:
(4) |
1. PPD test
2. contact dermatitis (including poison ivy) 3. MS (autoreactive against myelin prot's) 4. type 1 diabetes |
|
what's the predominant cause of cervical cancer?
|
HPV
|
|
immune surveillance =
|
immune system's ability to protect against *spontaneous* tumor cell growth
|
|
passive immunotherapy =
|
transfer of cellular (T, NK, PMN) or humoral product that results in therapeutic response
|
|
active immunotherapy =
|
therapy that induces patient's own immune system to target microbe/tumor
|
|
Phase 1 of clinical trials ~ prove that you're not:
|
hurting anyone
|
|
Phase 2 ~
|
does it work?
|
|
Phase 3 ~
|
shows improvement to overall survival
|
|
CD80/86 ~~
|
B7/CD28
|
|
CAR T cells stands for:
|
Chimeric Antigen Receptor T cell
|
|
CAR's are used to:
|
target *circulating* tumor cells
|
|
how do CAR's work?
|
take the antigen-recognizing portion of an AB and engineer it with a T cell
=> bring T cell to the tumor |
|
CAR's ~~
|
*active* immunotherapy
|
|
cytokines are also used for immunotherapy; they are produced by:
|
recombinant DNA technology
|
|
3 examples of cytokines used in immunotherapy:
|
1. interleukin 2
2. interferons 3. Granulocyte Stimulating Factors (GCSF) |
|
**what does anti-CTLA4 do?**
|
blocks CTLA4 => blocks inhibition of T cells => T cells turn ON against tumor cells
|
|
alloimmunity =
|
immunity gained from an individual of the same species
e.g. fetus antigens gain immunity |
|
allograft =
|
transfer of material between genetically non-identical individuals
|
|
2 examples of allografts:
|
1. blood transfusions
2. pregnancy |
|
autograft =
|
transferring materials within the same individual
|
|
isograft =
|
transferring material between genetically similar individuals (i.e. twins)
|
|
graft rejections are generally the result of:
|
differences in MHC
(T cells are the primary rejector) |
|
allogeneic =
|
immunologically dissimilar
|
|
**GVHD stands for:
|
graft vs. host disease
|
|
GVHD =
|
immune attack BY the transplanted cells against *the recipient*
|
|
for HLA transplants, the more genetic mismatches you have, the more likely:
|
your chance of GVHD
- aim to have no more than one mismatch |
|
what's the most significant problem with bone marrow transplants?
|
GVHD
|
|
GVHD is mitigated with:
|
reduction of bone marrow T cells in the recipient
|
|
3 phases of acute GVHD:
|
1. Conditioning phase
2. Activating phase 3. Effector phase |
|
Activation phase =
|
creation of Th1 cells out of donor T cells
|
|
Effector phase of GVHD =
|
tissue destruction by activated T cells' cytokines, etc.
|
|
***solid organ transplants:***
(2) |
1. ***recipient vs donor***
2. e.g. ABO antigens of organ get recognized as foreign => hyperacute rejection (b/c antigens already existed to that bloodtype) |
|
***stem cell transplant:***
|
***donor cells vs. recipient***
- T cells fight the new body they're in |
|
acute rejection takes:
|
1 to 3 weeks
solid organ acute rejection => organ eventually dies |
|
in **acute rejection,** recipient's T cells can recognize allogenic HLA mlcls in one of two ways:
|
1. directly
2. indirectly |
|
direct recognition of donor's HLA mlcls by T cells =
|
recipient’s T cells recognize donor peptides b/c the *donor's* HLA presents them
|
|
**indirect** recognition of donor's HLA mlcls by T cells =
|
recipient's T cells recognize donor peptides once they've been processed by the recipient's APC's and are presented by the recipient's HLA
|
|
chronic rejection takes:
|
>21 days
- results in death of the graft |
|
Practically all transplant patients require immunosuppression regardless of the:
|
HLA match
|
|
critical time-frame for seeing if a graft takes is:
|
2-4 weeks
|
|
triple therapy of immunosupression before a graft:
|
1. anti-inflammatories aka corticoids
2. DNA replication inhibitors 3. inhibitors of T cell activation (**cyclosporin/calneurin**) |
|
stem cell / "bone marrow" transplantation requires:
(3) |
1. HLA matching,
2. immune suppression of recipient 3. treatment of GVHD |
|
solid organ transplantation requires:
(3) |
1. ABO matching
2. immune suppression 3. monitoring of organs for chronic rejection (if acute rejection is averted) |